ESC 365 - Interrupted vs uninterrupted direct oral anticoagulants compared with uninterrupted vitamin K antagonists for atrial fibrillation ablation

Back

EHRA Premium Access

Interrupted vs uninterrupted direct oral anticoagulants compared with uninterrupted vitamin K antagonists for atrial fibrillation ablation - A meta-analysis of safety

Session: Atrial fibrillation catheter ablation complications (1)

Topic: Rhythm Control, Catheter Ablation

Speaker: Doctor D. Musat (Paramus, US)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Doctor Dan Musat

The Valley Hospital, Paramus (United States of America)

0 follower

5 more presentations in this session

A novel method for phrenic nerve monitoring during cryo-balloon procedures

Speaker: Doctor A. Marinelli (Palermo, IT)

Safety and efficacy of a nurse-led deep sedation protocol for invasive pulsed-field ablation of atrial fibrillation

Speaker: Doctor D. Rodriguez Munoz (Madrid, ES)

Analysis of hemolysis following pulse field ablation using three different technologies

Speaker: Doctor L. Marcon (Brussels, BE)

Left atrium size and the risk of atrio-esophageal fistula following thermal ablation in patients with atrial fibrillation

Speaker: Doctor A. Natale (Austin, US)

Cerebral safety of two different pulsed field ablation systems for pulmonary vein isolation: the TWOSOME MRI substudy

Speaker: Doctor S. Hartl (Essen, DE)

Access the full session

Atrial fibrillation catheter ablation complications (1)

Speakers: Doctor D. Musat, Doctor A. Marinelli, Doctor D. Rodriguez Munoz, Doctor L. Marcon, Doctor A. Natale...

Access

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources